Swelling lecithin: cholesterol implants for the controlled release of proteins

References

• Appel B, Maschke A, Weiser B, Sarhan H, Englert C, Angele P, et al. (2006). Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitro. Int J Pharm 314:170–178.
   PubMed Web of Science ®Google Scholar
• Binder H, Kohler G, Arnold K, Zschornig O. (2000). pH- and Ca2+-dependent interaction of Annexin V with phospholipid membranes: a combined study uisng fluorescence techniques, microelectrophoresis, and infrared spectroscopy. Phys Chem Chem Phys 2:4615–4623.
   Google Scholar
• Binder H, Zschornig O. (2002). The effect of metal cations on the phase behavior and hydration characteristics of phospholipid membranes. Chem Phys Lipids 115:39–61.
   PubMed Web of Science ®Google Scholar
• Casal HL, Mantsch HH. (1984). Polymorphic phase behaviour of phospholipid membranes studied by infrared spectroscopy. Biochim Biophys Acta 779:381–401.
   PubMed Web of Science ®Google Scholar
• Cevc G. (1993). Phospholipids Handbook. New York: Marcel Dekker, Inc.
   Google Scholar
• Colombo P, Bettini R, Massimo G, Catellani PL, Santi P, Peppas NA. (1995). Drug diffusion front movement is important in drug release control from swellable matrix tablets. J Pharm Sci 84:991–997.
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Santi P, Peppas NA. (2000). Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms, and optimal performance. Pharm Sci Technol Today 3:198–204.
   PubMedGoogle Scholar
• Crotts G, Park TG. (1997). Stability and release of bovine serum albumin encapsulated within poly(D, L-lactide-co-glycolide) microparticles. J Cont Rel 44:123–134.
   Web of Science ®Google Scholar
• Estey T, Kang J, Schwendeman SP, Carpenter JF. (2006). BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. J Pharm Sci 95:1626–1639.
   PubMed Web of Science ®Google Scholar
• Garcia-Manyes S, Oncins G, Sanz F. (2005). Effect of ion-binding and chemical phospholipid structure on the nanomechanics of lipid bilayers studied by force spectroscopy. Biophys J 89:1812–1826.
   PubMed Web of Science ®Google Scholar
• Grdadolnik J, Hadzi D. (1993). Conformational effects of metal salt binding to the polar head of phosphatidylcholines investigated by FTIR spectroscopy. Chem Phys Lipids 65:121–132.
   Google Scholar
• Guse C, Koennings S, Kreye F, Siepmann F, Goepferich A, Siepmann J. (2006). Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms. Int J Pharm 314:137–144.
   PubMed Web of Science ®Google Scholar
• Herrmann S, Mohl S, Siepmann F, Siepmann J, Winter G. (2007a). New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implants. Pharm Res 24:1527–1537.
   PubMed Web of Science ®Google Scholar
• Herrmann S, Winter G, Mohl S, Siepmann F, Siepmann J. (2007b). Mechanisms controlling protein release from lipidic implants: effects of PEG addition. J Contr Rel 118:161–168.
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. (2003). Physico-chemical stability of colloidal lipid particles. Biometerials 24:4283–4300.
   PubMed Web of Science ®Google Scholar
• Hubner W, Blume A. (1998). Interactions at the lipid-water interface. Chem Phys Lipids 96:99–123.
   Google Scholar
• Kendrick BS, Dong A, Allison SD, Manning MC, Carpenter JF. (1996). Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states. J Pharm Sci 85:155–158.
   PubMed Web of Science ®Google Scholar
• Khan MZI, Tucker IG, Opdebeeck JP. (1991). Cholesterol and lecithin implants for sustained release of antigen: release and erosion in vitro, and antibody response in mice. Int J Pharm 76:161–170.
   Google Scholar
• Khan MZI, Tucker IG, Opdebeeck, JP.(1993). Evaluation of cholesterol-lecithin implants for sustained delivery of antigen: release in vivo and single-step immunisation of mice. Int J Pharm 90:255–262.
   Google Scholar
• Koennings S, Garcion E, Faisant N, Menei P, Benoit JP, Gopferich A. (2006). In vitro investigation of lipid implants as a controlled release system for interleukin-18. Int J Pharm 314:145–152.
   PubMed Web of Science ®Google Scholar
• Korreman SS, Posselt D. (2001). Modification of anomalous swelling in multilamellar vesicles induced by alkali halide salts. Eur Biophys J 30:121–128.
   PubMed Web of Science ®Google Scholar
• Koynova R, Caffrey M. (1998). Phases and phase transitions of the phosphatidylcholines. Biochim Biophys Acta 1376:91–145.
   PubMed Web of Science ®Google Scholar
• Lis LJ, Parsegian VA, Rand RP. (1981). Binding of divalent cations of dipalmitoylphosphatidylcholine bilayers and its effect on bilayer interaction. Biochemistry 20:1761–1770.
   PubMed Web of Science ®Google Scholar
• Mohl S, Winter G. (2004). Continuous release of rh-interferon alpha-2a from triglyceride matrices. J Contr Rel 97:67–78.
   PubMed Web of Science ®Google Scholar
• Mohl S, Winter G. (2006). Continuous release of rh-interferon (alpha-2a from triglyceride implants: storage stability of the dosage forms. Pharm Dev Technol 11:103–110.
   PubMed Web of Science ®Google Scholar
• Petrache HI, Tristram-Nagle S, Harries D, Kucerka N, Nagle JF, Parsegian VA. (2006). Swelling of phospholipids by monovalent salt. J Lipid Res 47:302–309.
   PubMed Web of Science ®Google Scholar
• Pongjanyakul T, Medlicott NJ, Tucker IG. (2004). Melted glyceryl palmitostearate (GPS) pellets for protein delivery. Int J Pharm 271:53–62.
   PubMed Web of Science ®Google Scholar
• Reithmeier H, Herrmann J, Gopferich A. (2001). Lipid microparticles as a parenteral controlled release device for peptides. J Contr Rel 73:339–350.
   PubMed Web of Science ®Google Scholar
• Schule S, Friess W, Bechtold-Peters K, Garidel P. (2007). Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations. Eur J Pharm Biopharm 65:1–9.
   PubMed Web of Science ®Google Scholar
• Selle C, Pohle W. (1998). Fourier transform infrared spectroscopy as a probe for the study of the hydration of lipid self-assemblies. II. Water binding versus phase transitions. Biospectroscopy 4:281–294.
   Google Scholar
• Small DM. (1986). Handbook of Lipid Research. New York: Plenum Press.
   Google Scholar
• Tamber H, Johansen P, Merkle HP, Gander B. (2005). Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 57:357–376.
   PubMed Web of Science ®Google Scholar
• Tamm LK, Tatulian SA. (1997). Infrared spectroscopy of proteins and peptides in lipid bilayers. Quart Rev Biophys 30:365–429.
   PubMed Web of Science ®Google Scholar
• Tang W, Ciftci K. (2006). Commonly used analytical techniques for biotechnology products. In: (ed.) Groves MJ, Pharmaceutical Biotechnology (pp 147–178). Boca Raton: Taylor & Francis.
   Google Scholar
• Tantipolphan R, Rades T, McQuilan AJ, Medlicott NJ. (2007). Adsorption of bovine serum albumin (BSA) onto lecithin studied by attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy. Int J Pharm 337:40–47.
   PubMed Web of Science ®Google Scholar
• Tardi C, Brandl M, Schubert R. (1998). Erosion and controlled release properties of semisolid vesicular phospholipid dispersions. J Contr Rel 55:261–270.
   PubMed Web of Science ®Google Scholar
• Walduck AK, Opdebeeck JP, Benson HE, Prankerd R. (1998). Biodegradable implants for the delivery of veterinary vaccines: design, manufacture, and antibody responses in sheep. J Contr Rel 51:269–280.
   PubMed Web of Science ®Google Scholar
• Wang W. (1999). Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm 185:129–188.
   PubMed Web of Science ®Google Scholar